Elucidating the Rimosamide-Detoxin Natural Product Families and Their Biosynthesis Using Metabolite/Gene Cluster Correlations.

As microbial genome sequencing becomes more widespread, the capacity of microorganisms to produce an immense number of metabolites has come into better view. Utilizing a metabolite/gene cluster correlation platform, the biosynthetic origins of a new family of natural products, the rimosamides, were discovered. The rimosamides were identified in Streptomyces rimosus and associated with their NRPS/PKS-type gene cluster based upon their high frequency of co-occurrence across 179 strains of actinobacteria. This also led to the discovery of the related detoxin gene cluster. The core of each of these families of natural products contains a depsipeptide bond at the point of bifurcation in their unusual branched structures, the origins of which are definitively assigned to nonlinear biosynthetic pathways via heterologous expression in Streptomyces lividans. The rimosamides were found to antagonize the antibiotic activity of blasticidin S against Bacillus cereus.

[1]  B. Shen,et al.  Type I polyketide synthase requiring a discrete acyltransferase for polyketide biosynthesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Andrew W. Han,et al.  Genome streamlining and chemical defense in a coral reef symbiosis , 2012, Proceedings of the National Academy of Sciences.

[3]  R. Süssmuth,et al.  Biosynthetic gene cluster of the non-ribosomally synthesized cyclodepsipeptide skyllamycin: deciphering unprecedented ways of unusual hydroxylation reactions. , 2011, Journal of the American Chemical Society.

[4]  N. Kelleher,et al.  Cloning, expression, and biochemical characterization of Streptomyces rubellomurinus genes required for biosynthesis of antimalarial compound FR900098. , 2008, Chemistry & biology.

[5]  C. Hertweck,et al.  Triggering cryptic natural product biosynthesis in microorganisms. , 2009, Organic & biomolecular chemistry.

[6]  G. V. van Wezel,et al.  Natural product proteomining, a quantitative proteomics platform, allows rapid discovery of biosynthetic gene clusters for different classes of natural products. , 2014, Chemistry & biology.

[7]  Anna Lechner,et al.  Molecular networking and pattern-based genome mining improves discovery of biosynthetic gene clusters and their products from Salinispora species. , 2015, Chemistry & biology.

[8]  S. Lautru,et al.  An iterative nonribosomal peptide synthetase assembles the pyrrole-amide antibiotic congocidine in Streptomyces ambofaciens. , 2009, Chemistry & biology.

[9]  N. Kelleher,et al.  A Proteomics Approach to Discovery of Natural Products and Their Biosynthetic Pathways , 2009, Nature Biotechnology.

[10]  T. Zabriskie,et al.  The Blasticidin S Biosynthesis Gene Cluster from Streptomyces griseochromogenes: Sequence Analysis, Organization, and Initial Characterization , 2003, Chembiochem : a European journal of chemical biology.

[11]  W. Metcalf,et al.  Comparative genomics of actinomycetes with a focus on natural product biosynthetic genes , 2013, BMC Genomics.

[12]  Y. Yonehara,et al.  Effect of detoxin D on blasticidin S uptake inBacillus cereus , 1981, Experientia.

[13]  K. Reynolds,et al.  High titer production of tetracenomycins by heterologous expression of the pathway in a Streptomyces cinnamonensis industrial monensin producer strain. , 2009, Metabolic engineering.

[14]  Ryan A McClure,et al.  Proteomics guided discovery of flavopeptins: anti-proliferative aldehydes synthesized by a reductase domain-containing non-ribosomal peptide synthetase. , 2013, Journal of the American Chemical Society.

[15]  Neil L Kelleher,et al.  A Roadmap for Natural Product Discovery Based on Large-Scale Genomics and Metabolomics , 2014, Nature chemical biology.

[16]  H. Seto,et al.  The detoxin complex, selective antagonists of blasticidin S. , 1968, The Journal of antibiotics.

[17]  Christophe Corre,et al.  Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens , 2011, Proceedings of the National Academy of Sciences.

[18]  M. Mori,et al.  A novel dodecadepsipeptide, cereulide, is an emetic toxin of Bacillus cereus. , 1995, FEMS microbiology letters.

[19]  J. Nakayama,et al.  Arthroamide, a Cyclic Depsipeptide with Quorum Sensing Inhibitory Activity from Arthrobacter sp. , 2015, Journal of natural products.

[20]  J. C. Price,et al.  CD and MCD of CytC3 and taurine dioxygenase: role of the facial triad in alpha-KG-dependent oxygenases. , 2007, Journal of the American Chemical Society.

[21]  Shu-Lin Chang,et al.  Recent advances in awakening silent biosynthetic gene clusters and linking orphan clusters to natural products in microorganisms. , 2011, Current opinion in chemical biology.

[22]  Kai Blin,et al.  antiSMASH 2.0—a versatile platform for genome mining of secondary metabolite producers , 2013, Nucleic Acids Res..

[23]  A. Demain,et al.  Natural products for cancer chemotherapy , 2011, Microbial biotechnology.

[24]  William Fenical,et al.  Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica , 2007, Proceedings of the National Academy of Sciences.

[25]  R. Busa-Fekete,et al.  Antagonism between Bacteriostatic and Bactericidal Antibiotics Is Prevalent , 2014, Antimicrobial Agents and Chemotherapy.

[26]  Jacques Ravel,et al.  Chapter 8. Methods for in silico prediction of microbial polyketide and nonribosomal peptide biosynthetic pathways from DNA sequence data. , 2009, Methods in enzymology.

[27]  R. H. Baltz.  Renaissance in antibacterial discovery from actinomycetes. , 2008, Current opinion in pharmacology.

[28]  T. Hofmann,et al.  Depsipeptide Intermediates Interrogate Proposed Biosynthesis of Cereulide, the Emetic Toxin of Bacillus cereus , 2015, Scientific Reports.

[29]  J. Vederas,et al.  Drug Discovery and Natural Products: End of an Era or an Endless Frontier? , 2009, Science.

[30]  Timothy L. Foley,et al.  An orthogonal active site identification system (OASIS) for proteomic profiling of natural product biosynthesis. , 2009, ACS chemical biology.

[31]  Ryan A McClure,et al.  Metabologenomics: Correlation of Microbial Gene Clusters with Metabolites Drives Discovery of a Nonribosomal Peptide with an Unusual Amino Acid Monomer , 2016, ACS central science.

[32]  D. Newman,et al.  Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.

[33]  Neil L. Kelleher,et al.  Strain-specific proteogenomics accelerates the discovery of natural products via their biosynthetic pathways , 2014, Journal of Industrial Microbiology & Biotechnology.

[34]  H. Gross.  Strategies to unravel the function of orphan biosynthesis pathways: recent examples and future prospects , 2007, Applied Microbiology and Biotechnology.

[35]  John Mann,et al.  Natural products in cancer chemotherapy: past, present and future , 2002, Nature Reviews Cancer.

[36]  R. Subramani,et al.  Marine actinomycetes: an ongoing source of novel bioactive metabolites. , 2012, Microbiological research.

[37]  A Peptidyl-Transesterifying Type I Thioesterase in Salinamide Biosynthesis. , 2016, Angewandte Chemie.

[38]  David J Newman,et al.  Natural products: a continuing source of novel drug leads. , 2013, Biochimica et biophysica acta.

[39]  G. Szakács,et al.  Production of transglutaminase by Streptomyces isolates in solid‐state fermentation , 2008, Letters in applied microbiology.

[40]  B. Moore,et al.  Salinamides, Antiinflammatory Depsipeptides from a Marine Streptomycete , 1999 .

[41]  Kai Blin,et al.  NRPSpredictor2—a web server for predicting NRPS adenylation domain specificity , 2011, Nucleic Acids Res..